CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $51,000 | – | 13,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $19,497,000 | 100.00% |
| Meditor Group Ltd | 6,312,700 | $17,928,000 | 2.31% |
| TSP Capital Management Group, LLC | 1,278,057 | $3,630,000 | 1.65% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 10,772,111 | $30,593,000 | 0.46% |
| Virtus ETF Advisers LLC | 118,969 | $338,000 | 0.42% |
| Benchmark Capital Advisors | 61,000 | $173,000 | 0.14% |
| ASCEND CAPITAL, LLC | 873,995 | $2,482,000 | 0.09% |
| SHEPHERD KAPLAN KROCHUK, LLC | 44,521 | $126,000 | 0.08% |
| Vident Investment Advisory, LLC | 427,578 | $1,214,000 | 0.06% |
| NJ State Employees Deferred Compensation Plan | 80,000 | $227,000 | 0.04% |